Health state utilities associated with hyperphagia: Data for use in cost-utility models

被引:0
|
作者
Howell, Timothy A. [1 ,8 ]
Matza, Louis S. [1 ]
Mallya, Usha G. [2 ]
Goldstone, Anthony P. [3 ,4 ]
Butsch, W. Scott [5 ]
Lazarus, Ethan [6 ,7 ]
机构
[1] Evidera, Patient Ctr Res, Bethesda, MD USA
[2] Rhythm Pharmaceut Inc, Value & Evidence, Boston, MA USA
[3] Imperial Coll London, Dept Brain Sci, Div Psychiat, PsychoNeuroEndocrinol Res Grp, London, England
[4] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, Dept Endocrinol, London, England
[5] Cleveland Clin, Bariatr & Metab Inst, Cleveland Hts, OH USA
[6] Clin Nutr Ctr, Greenwood Village, CO USA
[7] Univ Colorado, Dept Family Med, Sch Med, Aurora, CO USA
[8] Evidera, Patient Ctr Res, 7101 Wisconsin Ave,Ste 1400, Bethesda, MD 20814 USA
来源
OBESITY SCIENCE & PRACTICE | 2023年 / 9卷 / 04期
关键词
health state utilities; hyperphagia; obesity; time trade-off; QUALITY-OF-LIFE; PRADER-WILLI-SYNDROME; OBESITY; OVERWEIGHT; SIBLINGS;
D O I
10.1002/osp4.652
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveRare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperphagia. This study estimated utilities associated with various hyperphagia severity levels. MethodsFour health state vignettes were developed using published literature and clinician input to represent various severity levels of hyperphagia. Utilities were estimated for these health states in a time trade-off elicitation study in a UK general population sample. ResultsIn total, 215 participants completed interviews (39.5% male; mean age 39.1 years). Mean (SD) utilities were 0.98 (0.02) for no hyperphagia, 0.91 (0.10) for mild hyperphagia, 0.70 (0.30) for moderate hyperphagia, and 0.22 (0.59) for severe hyperphagia. Mean (SD) disutilities were -0.08 (0.10) for mild, -0.28 (0.30) for moderate, and -0.77 (0.58) for severe hyperphagia. ConclusionsThese data show increasing severity of hyperphagia is associated with decreased utility. Utilities associated with severe hyperphagia are similar to those of other health conditions severely impacting quality of life (QoL). These findings highlight that treatments addressing substantial QoL impacts of severe hyperphagia are needed. Utilities estimated here may be useful in cost-utility models of treatments for rare genetic diseases of obesity.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [31] An Educational Review of the Statistical Issues in Analysing Utility Data for Cost-Utility Analysis
    Hunter, Rachael Maree
    Baio, Gianluca
    Butt, Thomas
    Morris, Stephen
    Round, Jeff
    Freemantle, Nick
    PHARMACOECONOMICS, 2015, 33 (04) : 355 - 366
  • [32] Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?
    Yang, Fan
    Devlin, Nancy
    Luo, Nan
    VALUE IN HEALTH, 2019, 22 (01) : 45 - 49
  • [33] Estimating the Education-Health Relationship: A Cost-Utility Approach
    Golberstein, Ezra
    Hirth, Richard A.
    Lantz, Paula M.
    B E JOURNAL OF ECONOMIC ANALYSIS & POLICY, 2011, 11 (03):
  • [34] Methods for Measuring Temporary Health States for Cost-Utility Analyses
    Davene R. Wright
    Eve Wittenberg
    J. Shannon Swan
    Rebecca A. Miksad
    Lisa A. Prosser
    PharmacoEconomics, 2009, 27 : 713 - 723
  • [35] THE TENSION BETWEEN COST-UTILITY ANALYSIS AND PREVENTIVE PUBLIC HEALTH
    Hyun, I.
    MEDICINE AND LAW, 2006, 25 (03): : 483 - 490
  • [36] A second opinion - Cost-utility analysis and varying preferences for health
    Mooney, G
    Jan, S
    HEALTH POLICY, 1997, 41 (03) : 201 - 203
  • [37] COST-UTILITY ANALYSIS IN THE EVALUATION OF PERINATAL HEALTH-CARE
    DERHAM, R
    LANCET, 1986, 2 (8503): : 399 - 399
  • [38] Using rank data to estimate health state utility models
    McCabe, C
    Brazier, J
    Gilks, P
    Tsuchiya, A
    Roberts, J
    O'Hagan, A
    Stevens, K
    JOURNAL OF HEALTH ECONOMICS, 2006, 25 (03) : 418 - 431
  • [39] Methods for Measuring Temporary Health States for Cost-Utility Analyses
    Wright, Davene R.
    Wittenberg, Eve
    Swan, J. Shannon
    Miksad, Rebecca A.
    Prosser, Lisa A.
    PHARMACOECONOMICS, 2009, 27 (09) : 713 - 723
  • [40] Cost-utility analysis: Use QALYs only with great caution
    McGregor, M
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 168 (04) : 433 - 434